{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:04:35Z","timestamp":1781147075283,"version":"3.54.1"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                        <jats:title>Background:<\/jats:title>\n                        <jats:p>Among various carboxylic acid derivatives, valeric acid or pentanoic acid\nis found to be widely distributed in nature. It is a straight-chain alkyl carboxylic acid containing\nfive carbon atoms. Due to the therapeutic value of valeric acid, it is used as a versatile nucleus in\nthe pharmaceutical field. Valeric acid derivatives are associated with a broad spectrum of biological\nactivities, like anticonvulsant, antiplatelet, antidiabetic, and plant growth activities.<\/jats:p>\n                    <\/jats:sec>\n                    <jats:sec>\n                        <jats:title>Aim:<\/jats:title>\n                        <jats:p>It has previously been revealed that peptide derivatives of carboxylic acids are accountable\nfor enhanced antimicrobial activity. Therefore, it was hypothesized that coupling peptides with\nvaleric acid would increase the antimicrobial properties of the target compounds. So, the objective\nof the present study was to synthesize peptide derivatives of 5-bromovaleric acid and evaluate their\nantibacterial and antifungal activities.<\/jats:p>\n                    <\/jats:sec>\n                    <jats:sec>\n                        <jats:title>Methods:<\/jats:title>\n                        <jats:p>5-bromovaleric acid was synthesized by the reaction of cyclopentanone and hydrogen\nperoxide in the presence of copper bromide and sodium bromide. Additionally, 5-bromovaleric acid\nwas coupled with amino acid methyl esters, dipeptides, tripeptides, and tetrapeptides in the presence\nof dicyclohexylcarbodimide (DCC) and N-methylmorpholine (NMM) as a base under continuous\nstirring for 36 hours to produce its peptide derivatives.<\/jats:p>\n                    <\/jats:sec>\n                    <jats:sec>\n                        <jats:title>Results:<\/jats:title>\n                        <jats:p>The results obtained showed that 5-bromovaleric acid possesses more potent antibacterial\nactivity than N-terminal 5-bromovaleric acid conjugates of selected di-, tri, and tetra peptide Cterminal\nmethyl esters against ciprofloxacin as a standard. The selected dipeptide and tripeptide Nterminal\n5-bromovaleric acid-conjugated C-terminal methyl ester derivatives were more active than\nthe selected tetrapeptide methyl ester analogue. Using fluconazole as a reference, the antifungal\nefficacy of 5-bromovaleric acid against C. albicans and A. niger declined as it was combined with\nC-terminal methyl esters of selected dipeptides, tripeptides, and tetrapeptides.<\/jats:p>\n                    <\/jats:sec>\n                    <jats:sec>\n                        <jats:title>Conclusion:<\/jats:title>\n                        <jats:p>The novel selected peptide derivatives had less antibacterial and antifungal action than\nthe parent 5-bromovaleric acid. Antibacterial and antifungal investigations showed that 5-\nbromopentanoic acid peptide derivatives might impair antimicrobial efficacy. Further, attaching 5-\nbromopentanoic acid to di, tri, and tetra peptides did not boost their antibacterial potential.<\/jats:p>\n                    <\/jats:sec>","DOI":"10.2174\/0115734064302733240621054643","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T07:53:26Z","timestamp":1720598006000},"page":"950-956","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis and Biological Evaluation of Amino Acid and Peptide Conjugates of 5-Bromovaleric Acid"],"prefix":"10.2174","volume":"20","author":[{"given":"Saurav","family":"Kumar","sequence":"first","affiliation":[{"name":"GNA School of Pharmacy, Shri Hargobindgarh, Phagwara, District Kapurthala, 144401, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"University\nInstitute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical\nChemistry, Delhi Pharmaceutical Sciences &amp; Research University, Pushp Vihar, New Delhi - 110017, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Verma","sequence":"additional","affiliation":[{"name":"Chitkara\nUniversity School of Pharmacy, Chitkara University, Baddi, Himachal Pradesh, 174103, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of\nPharmaceutical Chemistry, Shivalik College of Pharmacy, Nangal, 140126, Ropar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470571224.pse416","author":"David H.F.","year":"2011","unstructured":"David H.F.;  Current needs for new therapeutic agents and discovery strategies\u2014a systems pharmacology approach Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing  2011","journal-title":"Current needs for new therapeutic agents and discovery strategies\u2014a systems pharmacology approach Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/molecules27020349","volume":"27","author":"Najmi A.","year":"2022","unstructured":"Najmi A.; Javed S.A.; Bratty Al.; Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents. Molecules  2022,27(2),349","journal-title":"Molecules"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1201419","DOI":"10.3389\/fddsv.2023.1201419","volume":"3","author":"Singh N.","year":"2023","unstructured":"Singh N.; Vayer P.; Tanwar S.; Poyet J-L.; Tsaioun K.; Villoutreix B.O.; Drug discovery and development: Introduction to the general public and patient groups. Front Drug Dis  2023,3,1201419","journal-title":"Front Drug Dis"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-820472-6.00041-4","author":"Dzobo K.","year":"2022","unstructured":"Dzobo K.;  The role of natural products as sources of therapeutic agents for innovative drug discovery Comprehensive Pharmacology  2022","journal-title":"The role of natural products as sources of therapeutic agents for innovative drug discovery Comprehensive Pharmacology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.drudis.2021.09.017","volume":"27","author":"Maurer T.S.","year":"2022","unstructured":"Maurer T.S.; Edwards M.; Hepworth D.; Verhoest P.; Allerton C.M.N.; Designing small molecules for therapeutic success: A contemporary perspective. Drug Discov Today  2022,27(2),538-546","journal-title":"Drug Discov Today"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.9754\/journal.wmc.2012.003551","volume":"3","author":"Rajeev K.","year":"2012","unstructured":"Rajeev K.; Traditional systems of medicine-now and forever. Webmed Central Pharmaceut Sci  2012,3(7),2-5","journal-title":"Webmed Central Pharmaceut Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"376327","DOI":"10.1155\/2013\/376327","volume":"2013","author":"Pandey M.M.","year":"2013","unstructured":"Pandey M.M.; Rastogi S.; Rawat A.K.; Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med  2013,2013,376327","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=8","first-page":"S51","volume":"8","author":"Chao Z.","year":"2021","unstructured":"Chao Z.; Traditional medicine in India. J Trad Chin Med Sci  2021,8(1),S51-S55","journal-title":"J Trad Chin Med Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/plants10050846","volume":"10","author":"Das G.","year":"2021","unstructured":"Das G.; Shin H.S.; Tundis R.; Gon\u00e7alves S.; Tantengco O.A.G.; Campos M.G.; Acquaviva R.; Malfa G.A.; Romano A.; Robles J.A.H.; Clores M.Q.; Patra J.K.; Plant species of sub-family Valerianaceae\u2014A review on its effect on the central nervous system. Plants  2021,10(5),846","journal-title":"Plants"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e70280","DOI":"10.5209\/mbot.70280","volume":"42","author":"S\u00e1nchez M.","year":"2021","unstructured":"S\u00e1nchez M.; Gonz\u00e1lez-Burgos E.; Iglesias I.; G\u00f3mez-Serranillos Cuadrado M.P.; Updating the biological interest of \u2018Valeriana officinalis\u2019. Mediter Botany  2021,42,e70280","journal-title":"Mediter Botany"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00210-023-02392-x","volume":"396","author":"Batiha G.E.S.","year":"2023","unstructured":"Batiha G.E.S.; Teibo J.O.; Wasef L.; Shaheen H.M.; Akomolafe A.P.; Teibo T.K.A.; Al-kuraishy H.M.; Al-Garbeeb A.I.; Alexiou A.; Papadakis M.; A review of the bioactive components and pharmacological properties of Lavandula species. Naunyn Schmiedebergs Arch Pharmacol  2023,396(5),877-900","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0014-827X(03)00092-2","volume":"58","author":"Poojary B.","year":"2003","unstructured":"Poojary B.; Belagali S.L.; Harish Kumar K.; Holla B.S.; Synthetic and antibacterial studies on some new furanopeptides. Il Farmaco  2003,58(8),569-572","journal-title":"Il Farmaco"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1023\/A:1020561127636","volume":"36","author":"Levit G.L.","year":"2002","unstructured":"Levit G.L.; Anikina L.V.; Vikharev Y.B.; Demin A.M.; Safin V.A.; Matveeva T.V.; Krasnov V.P.; Synthesis and antiinflammatory and analgesic activity of naproxen amides with amino acid derivatives. Pharmaceut Chem J  2002,36,232-236","journal-title":"Pharmaceut Chem J"},{"key":"ref=14","first-page":"450","volume":"142","author":"Himaja M.","year":"2003","unstructured":"Himaja M.; Synthesis and biological activity of a novel series of 4-[2\u02b9-(6\u02b9-nitro)-benzimidazolyl]benzoyl amino acids and peptides. Boll Chim Farm  2003,142,450-453","journal-title":"Boll Chim Farm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.32553\/jbpr.v8i3.631","volume":"28","author":"Ramninder K.","year":"2014","unstructured":"Ramninder K.; Synthesis and biological evaluation of gallic acid peptide derivatives. Int J Pharm Sci  2014,28(1),16-21","journal-title":"Int J Pharm Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.omto.2020.08.017","volume":"19","author":"Han R.","year":"2020","unstructured":"Han R.; Nusbaum O.; Chen X.; Zhu Y.; Valeric acid suppresses liver cancer development by acting as a novel HDAC inhibitor. Mol Ther Oncolytics  2020,19,8-18","journal-title":"Mol Ther Oncolytics"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/foods12030636","volume":"12","author":"Wu C.R.","year":"2023","unstructured":"Wu C.R.; Lee S.Y.; Chen C.H.; Lin S.D.; Bioactive compounds of underground valerian extracts and their effect on inhibiting metabolic syndrome-related enzymes activities. Foods  2023,12(3),636","journal-title":"Foods"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1016\/j.ejmech.2011.07.034","volume":"46","author":"Vuji\u0107 J.M.","year":"2011","unstructured":"Vuji\u0107 J.M.; Kalu\u0111erovi\u0107 G.N.; Milovanovi\u0107 M.; Zmejkovski B.B.; Volarevi\u0107 V.; \u017divi\u0107 D.; \u0110ur\u0111evi\u0107 P.; Arsenijevi\u0107 N.; Trifunovi\u0107 S.R.; Stereospecific ligands and their complexes. Part VII. Synthesis, characterization and in vitro antitumoral activity of platinum(II) complexes with O,O\u2032-dialkyl esters of (S,S)-ethylenediamine-N,N\u2032-di-2-(4-methyl)pentanoic acid. Eur J Med Chem  2011,46(9),4559-4565","journal-title":"Eur J Med Chem"},{"key":"ref=19","first-page":"89","volume":"14","author":"Song M.X.","year":"2015","unstructured":"Song M.X.; Deng X.Q.; Wei Z.Y.; Zheng C.J.; Wu Y.; An C.S.; Piao H.R.; Synthesis and Antibacterial Evaluation of (S,Z)-4-methyl-2-(4-oxo-5-((5-substituted phenylfuran-2-yl) methylene)-2-thioxothiazolidin-3-yl)Pentanoic Acids. Iran J Pharm Res  2015,14(1),89-96","journal-title":"Iran J Pharm Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.3390\/molecules24203770","volume":"24","author":"Kovanda L.","year":"2019","unstructured":"Kovanda L.; Zhang W.; Wei X.; Luo J.; Wu X.; Atwill E.R.; Vaessen S.; Li X.; Liu Y.; In vitro antimicrobial activities of organic acids and their derivatives on several species of gram-negative and gram-positive bacteria. Molecules  2019,24(20),3770","journal-title":"Molecules"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.3390\/molecules18044373","volume":"18","author":"Chandrudu S.","year":"2013","unstructured":"Chandrudu S.; Simerska P.; Toth I.; Chemical methods for peptide and protein production. Molecules  2013,18(4),4373-4388","journal-title":"Molecules"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"18.1.1","DOI":"10.1002\/0471140864.ps1801s69","volume":"18","author":"Stawikowski M.","year":"2012","unstructured":"Stawikowski M.; Fields G.B.; Introduction to peptide synthesis. Curr Protoc Protein Sci  2012,18,18.1.1-18.1.13","journal-title":"Curr Protoc Protein Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"32658","DOI":"10.1039\/C4RA02458C","volume":"4","author":"Palomo J.M.","year":"2014","unstructured":"Palomo J.M.; Solid-phase peptide synthesis: An overview focused on the preparation of biologically relevant peptides. RSC Advances  2014,4(62),32658-32672","journal-title":"RSC Advances"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0076-6879(77)47050-2","volume":"47","author":"Doscher M.S.","year":"1977","unstructured":"Doscher M.S.; Solid-phase peptide synthesis. Methods Enzymol  1977,47,578-617","journal-title":"Methods Enzymol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/psc.2958","volume":"23","author":"H\u00fampola M.V.","year":"2017","unstructured":"H\u00fampola M.V.; Rey M.C.; Carballeira N.M.; Simonetta A.C.; Tonarelli G.G.; Biological and structural effects of the conjugation of an antimicrobial decapeptide with saturated, unsaturated, methoxylated and branched fatty acids. J Pept Sci  2017,23(1),45-55","journal-title":"J Pept Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/ph16060892","volume":"16","author":"Helmy N.M.","year":"2023","unstructured":"Helmy N.M.; Parang K.; Cyclic peptides with antifungal properties derived from bacteria, fungi, plants, and synthetic sources. Pharmaceuticals (Basel)  2023,16(6),892","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"105866","DOI":"10.1016\/j.micpath.2022.105866","volume":"173","author":"Madanchi H.","year":"2022","unstructured":"Madanchi H.; Rahmati S.; Doaei Y.; Determination of antifungal activity and action mechanism of the modified Aurein 1.2 peptide derivatives. Microb Pathog  2022,173(Pt A),105866","journal-title":"Microb Pathog"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"24250","DOI":"10.1039\/D3RA04100J","volume":"13","author":"Tivari S.R.","year":"2023","unstructured":"Tivari S.R.; Kokate S.V.; Delgado-Alvarado E.; Gayke M.S.; Kotmale A.; Patel H.; Ahmad I.; Sobhia E.M.; Kumar S.G.; Lara B.G.; Jain V.D.; Jadeja Y.; A novel series of dipeptide derivatives containing indole-3-carboxylic acid conjugates as potential antimicrobial agents: The design, solid phase peptide synthesis, in vitro biological evaluation, and molecular docking study. RSC Advances  2023,13(35),24250-24263","journal-title":"RSC Advances"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3390\/ijms24032694","volume":"24","author":"Howan D.H.O.","year":"2023","unstructured":"Howan D.H.O.; Jenei S.; Szolomajer J.; Endre G.; Kondorosi \u00c9.; T\u00f3th G.K.; Enhanced antibacterial activity of substituted derivatives of NCR169C peptide. Int J Mol Sci  2023,24(3),2694","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"103163","DOI":"10.1016\/j.bioorg.2019.103163","volume":"92","author":"Zhang J.","year":"2019","unstructured":"Zhang J.; Wen H.; Shen F.; Wang X.; Shan C.; Chai C.; Liu J.; Li W.; Synthesis and biological evaluation of a novel series of curcumin-peptide derivatives as PepT1-mediated transport drugs. Bioorg Chem  2019,92,103163","journal-title":"Bioorg Chem"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1039\/C8NJ00383A","volume":"42","author":"Ghalehshahi H.G.","year":"2018","unstructured":"Ghalehshahi H.G.; Balalaie S.; Aliahmadi A.; Peptides N-connected to hydroxycoumarin and cinnamic acid derivatives: synthesis and fluorescence spectroscopic, antioxidant and antimicrobial properties. New J Chem  2018,42(11),8831-8842","journal-title":"New J Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3762\/bjoc.15.82","volume":"15","author":"Khalesi M.","year":"2019","unstructured":"Khalesi M.; Ziyaei Halimehjani A.; Martens J.; Synthesis of a novel category of pseudo-peptides using an Ugi three-component reaction of levulinic acid as bifunctional substrate, amines, and amino acid-based isocyanides. Beilstein J Org Chem  2019,15,852-857","journal-title":"Beilstein J Org Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00726-018-2661-0","volume":"51","author":"Khalesi M.","year":"2019","unstructured":"Khalesi M.; Halimehjani A.Z.; Franz M.; Schmidtmann M.; Martens J.; Ensembling three multicomponent reactions for the synthesis of a novel category of pseudo-peptides containing dithiocarbamate and N,X-heterocylic groups. Amino Acids  2019,51(2),263-272","journal-title":"Amino Acids"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.14233\/ajchem.2015.17914","volume":"27","author":"Li T.","year":"2015","unstructured":"Li T.; Singh S.; Zhai X.; Meng X.; Singh R.K.; Microwave-assisted synthesis, in silico ADME prediction and antibacterial study of 2-(substituted acetamido)-5-nitrobenzophenone derivatives. Asian J Chem  2015,27(7),2452-2456","journal-title":"Asian J Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/1573406416666200512073640","volume":"17","author":"Sethi N.S.","year":"2021","unstructured":"Sethi N.S.; Prasad D.N.; Singh R.K.; Synthesis, anticancer, and antibacterial studies of benzylidene bearing 5-substituted and 3,5-disubstituted-2,4-thiazolidinedione derivatives. Med Chem  2021,17(4),369-379","journal-title":"Med Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064302733240621054643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231701\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064302733240621054643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:53:27Z","timestamp":1729680807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231701\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064302733240621054643","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}